Target intelligence / Profile preview

Co-repressor of Repressor Element-1 Silencing Transcription complex (CoREST) (CoREST)

Target
CoREST
Molecular classification
Enzyme, Epigenetic regulator, Histone modification, Protein complex
01

Overview

The Co-repressor of Repressor Element-1 Silencing Transcription (CoREST) complex is an epigenetic regulatory assembly that includes histone deacetylase 1 (HDAC1) and the scaffold protein RCOR1. It plays a critical role in gene silencing by modifying chromatin structure through histone deacetylation. In the context of oncology, the CoREST complex has been identified as a synthetic lethal target for cancers harboring loss-of-function mutations in the STK11 (LKB1) tumor suppressor gene. Inhibition of the CoREST complex, specifically the HDAC1-containing form, reverses the immune evasion phenotype associated with STK11 deficiency by promoting the expression of immunomodulatory genes and increasing T-cell infiltration into the tumor microenvironment. Drugs like TNG260 are designed to selectively inhibit this complex to sensitize STK11-mutant tumors to immune checkpoint inhibitors such as anti-PD-1 antibodies.

Other names
RCOR1 complexHDAC1-CoREST complexTarget 3 (Tango Therapeutics)REST corepressor 1 complex
02

Mechanism of action

Selective inhibition of the HDAC1-containing CoREST complex, which leads to the accumulation of acetylated histones, chromatin remodeling, and transcriptional reprogramming. This process reverses the immune evasion phenotype in STK11-deficient cancer cells by upregulating immunomodulatory genes and promoting the recruitment of effector T cells, thereby sensitizing the tumor to immune checkpoint inhibitors.

03

Biological functions

Gene expression regulationChromatin remodelingImmune responseCell cycle regulation
04

Disease associations

CancerNon-small cell lung cancerCervical cancerPancreatic cancerBreast cancer
05

Safety considerations

CytopeniaNeutropeniaThrombocytopeniaFatigueGastrointestinal toxicity
06

Interacting drugs

TNG260
07

Biomarkers

STK11 (LKB1) loss-of-function mutationKRAS wild-type statusPD-L1 expressionIntratumoral T-cell infiltration

Beyond the preview

Go deeper on Co-repressor of Repressor Element-1 Silencing Transcription complex (CoREST) (CoREST).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Co-repressor of Repressor Element-1 Silencing Transcription complex (CoREST) (CoREST).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call